Focused Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,308
Closed -$87.7K 204
2024
Q3
$87.7K Sell
1,308
-859
-40% -$70.5K 0.01% 221
2024
Q2
$246K Buy
+2,167
New +$274K 0.04% 158
2024
Q1
Sell
-121
Closed -$15K 401
2023
Q4
$15K Hold
121
﹤0.01% 478
2023
Q3
$11.3K Hold
121
﹤0.01% 504
2023
Q2
$15.6K Hold
121
﹤0.01% 470
2023
Q1
$14.1K Sell
121
-549
-82% -$61.5K ﹤0.01% 490
2022
Q4
$75.9K Buy
670
+550
+458% +$60.4K 0.02% 244
2022
Q3
$10K Hold
120
﹤0.01% 490
2022
Q2
$9K Hold
120
﹤0.01% 507
2022
Q1
$15K Sell
120
-8
-6% -$875 ﹤0.01% 489
2021
Q4
$17K Buy
128
+8
+7% +$1.15K ﹤0.01% 507
2021
Q3
$16K Hold
120
﹤0.01% 534
2021
Q2
$13K Hold
120
﹤0.01% 571
2021
Q1
$11K Hold
120
﹤0.01% 584
2020
Q4
$11K Buy
120
+60
+100% +$5.36K ﹤0.01% 546
2020
Q3
$6K Buy
60
+40
+200% +$4.18K ﹤0.01% 579
2020
Q2
$2K Buy
+20
New +$1.79K ﹤0.01% 667

Other funds holding DXCM

Focused Wealth Management's DXCM Position: Q4 2024 in Review

Focused Wealth Management sold out of DexCom (DXCM) in Q4 2024, closing a stake of 1,308 shares — an estimated $87.7K sold.

Focused Wealth Management first reported a position in DXCM in Q2 2020 and held it in 17 quarters. The position peaked at $246K in Q2 2024. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

  • Focused Wealth Management reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
  • Focused Wealth Management sold 1,308 DexCom shares in Q4 2024, an estimated $87.7K.
  • Focused Wealth Management first reported a position in DexCom in Q2 2020 and held it in 17 quarters.
  • Focused Wealth Management's DexCom position peaked at $246K in Q2 2024.
  • 950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on Focused Wealth Management's 13F filing for Q4 2024, filed 28 Jan 2025.